Gentianine [Gentianaceae; Gentiana scabra Bunge] could be used as a potential anti-ischemic stroke agent by suppressing inflammatory responses via TLR4/NF-κB signaling pathway. This evidence concerns the gene TLR4 and ischemic stroke.